
Provider: Nature Publishing Group
Content: application/x-research-info-systems
TY  - JOUR
AU  - Pepys, M. B.
AU  - Hirschfield, G. M.
TI  - C-reactive protein: a critical update
JA  - J. Clin. Invest.
PY  - 2003///
VL  - 111
SP  - 1805
EP  - 1812
M3  - 10.1172/JCI200318921
N1  - 10.1172/JCI200318921
UR  - http://dx.doi.org/10.1172/JCI200318921
ER  -

TY  - JOUR
AU  - Griselli, M.
TI  - C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction
JA  - J. Exp. Med.
PY  - 1999///
VL  - 190
SP  - 1733
EP  - 1739
M3  - 10.1084/jem.190.12.1733
N1  - 10.1084/jem.190.12.1733
UR  - http://dx.doi.org/10.1084/jem.190.12.1733
ER  -

TY  - JOUR
AU  - Gill, R.
AU  - Kemp, J. A.
AU  - Sabin, C.
AU  - Pepys, M. B.
TI  - Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats
JA  - J. Cereb. Blood Flow Metab.
PY  - 2004///
VL  - 24
SP  - 1214
EP  - 1218
M3  - 10.1097/01.WCB.0000136517.61642.99
N1  - 10.1097/01.WCB.0000136517.61642.99
UR  - http://dx.doi.org/10.1097/01.WCB.0000136517.61642.99
ER  -

TY  - JOUR
AU  - de Beer, F. C.
TI  - Isolation and characterisation of C-reactive protein and serum amyloid P component in the rat
JA  - Immunology
PY  - 1982///
VL  - 45
SP  - 55
EP  - 70
ER  -

TY  - JOUR
AU  - Thompson, D.
AU  - Pepys, M. B.
AU  - Wood, S. P.
TI  - The physiological structure of human C-reactive protein and its complex with phosphocholine
JA  - Structure
PY  - 1999///
VL  - 7
SP  - 169
EP  - 177
M3  - 10.1016/S0969-2126(99)80023-9
N1  - 10.1016/S0969-2126(99)80023-9
UR  - http://dx.doi.org/10.1016/S0969-2126(99)80023-9
ER  -

TY  - JOUR
AU  - Pepys, M. B.
TI  - Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis
JA  - Nature
PY  - 2002///
VL  - 417
SP  - 254
EP  - 259
M3  - 10.1038/417254a
N1  - 10.1038/417254a
UR  - http://dx.doi.org/10.1038/417254a
ER  -

TY  - JOUR
AU  - Eda, S.
AU  - Kaufmann, J.
AU  - Roos, W.
AU  - Pohl, S.
TI  - Development of a new microparticle-enhanced turbidometric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range
JA  - J. Clin. Lab. Anal.
PY  - 1998///
VL  - 12
SP  - 137
EP  - 144
M3  - 10.1002/(SICI)1098-2825(1998)12:3<137::AID-JCLA2>3.0.CO;2-6
N1  - 10.1002/(SICI)1098-2825(1998)12:3<137::AID-JCLA2>3.0.CO;2-6
UR  - http://dx.doi.org/10.1002/(SICI)1098-2825(1998)12:3<137::AID-JCLA2>3.0.CO;2-6
ER  -

TY  - JOUR
AU  - Kushner, I.
AU  - Broder, M. L.
AU  - Karp, D.
TI  - Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction
JA  - J. Clin. Invest.
PY  - 1978///
VL  - 61
SP  - 235
EP  - 242
ER  -

TY  - JOUR
AU  - de Beer, F. C.
TI  - Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction
JA  - Br. Heart J.
PY  - 1982///
VL  - 47
SP  - 239
EP  - 243
ER  -

TY  - JOUR
AU  - Taylor, K. E.
AU  - Giddings, J. C.
AU  - van den Berg, C. W.
TI  - C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide
JA  - Arterioscler. Thromb. Vasc. Biol.
PY  - 2005///
VL  - 25
SP  - 1225
EP  - 1230
ER  -

TY  - JOUR
AU  - Pepys, M. B.
TI  - CRP or not CRP? That is the question
JA  - Arterioscler. Thromb. Vasc. Biol.
PY  - 2005///
VL  - 25
SP  - 1091
EP  - 1094
ER  -

TY  - JOUR
AU  - Pepys, M. B.
TI  - Pro-inflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products not by C-reactive protein itself
JA  - Circ. Res.
PY  - 2005///
VL  - 97
SP  - e97
EP  - 103
M3  - 10.1161/01.RES.0000193595.03608.08
N1  - 10.1161/01.RES.0000193595.03608.08
UR  - http://dx.doi.org/10.1161/01.RES.0000193595.03608.08
ER  -

TY  - JOUR
AU  - Clapp, B. R.
TI  - Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability
JA  - Circulation
PY  - 2005///
VL  - 111
SP  - 1530
EP  - 1536
M3  - 10.1161/01.CIR.0000159336.31613.31
N1  - 10.1161/01.CIR.0000159336.31613.31
UR  - http://dx.doi.org/10.1161/01.CIR.0000159336.31613.31
ER  -

TY  - JOUR
AU  - Hirschfield, G. M.
TI  - Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice
JA  - Proc. Natl Acad. Sci. USA
PY  - 2005///
VL  - 102
SP  - 8309
EP  - 8314
M3  - 10.1073/pnas.0503202102
N1  - 10.1073/pnas.0503202102
UR  - http://dx.doi.org/10.1073/pnas.0503202102
ER  -

TY  - JOUR
AU  - Ledue, T. B.
TI  - Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum
JA  - Ann. Clin. Biochem.
PY  - 1998///
VL  - 35
SP  - 745
EP  - 753
ER  -

TY  - JOUR
AU  - Nelson, S. R.
TI  - Serum amyloid P component in chronic renal failure and dialysis
JA  - Clin. Chim. Acta
PY  - 1991///
VL  - 200
SP  - 191
EP  - 200
M3  - 10.1016/0009-8981(91)90090-Y
N1  - 10.1016/0009-8981(91)90090-Y
UR  - http://dx.doi.org/10.1016/0009-8981(91)90090-Y
ER  -

TY  - JOUR
AU  - Bhakdi, S.
AU  - Torzewski, M.
AU  - Klouche, M.
AU  - Hemmes, M.
TI  - Complement and atherogenesis. Binding of CRP to degraded, nonoxidized LDL enhances complement activation
JA  - Arterioscler. Thromb. Vasc. Biol.
PY  - 1999///
VL  - 19
SP  - 2348
EP  - 2354
ER  -

TY  - JOUR
AU  - Hawkins, P. N.
AU  - Tennent, G. A.
AU  - Woo, P.
AU  - Pepys, M. B.
TI  - Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis
JA  - Clin. Exp. Immunol.
PY  - 1991///
VL  - 84
SP  - 308
EP  - 316
ER  -

TY  - JOUR
AU  - Gray, G. A.
AU  - Mickley, E. J.
AU  - Webb, D. J.
AU  - McEwan, P. E.
TI  - Localization and function of ET-1 and ET receptors in small arteries post-myocardial infarction: upregulation of smooth muscle ETB receptors that modulate contraction
JA  - Br. J. Pharmacol.
PY  - 2000///
VL  - 130
SP  - 1735
EP  - 1744
M3  - 10.1038/sj.bjp.0703503
N1  - 10.1038/sj.bjp.0703503
UR  - http://dx.doi.org/10.1038/sj.bjp.0703503
ER  -

TY  - JOUR
AU  - Miller, A. A.
AU  - Megson, I. L.
AU  - Gray, G. A.
TI  - Inducible nitric oxide synthase-derived superoxide contributes to hypereactivity in small mesenteric arteries from a rat model of chronic heart failure
JA  - Br. J. Pharmacol.
PY  - 2000///
VL  - 131
SP  - 29
EP  - 36
M3  - 10.1038/sj.bjp.0703528
N1  - 10.1038/sj.bjp.0703528
UR  - http://dx.doi.org/10.1038/sj.bjp.0703528
ER  -

TY  - JOUR
AU  - Mora, A.
TI  - Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia
JA  - EMBO J.
PY  - 2003///
VL  - 22
SP  - 4666
EP  - 4676
M3  - 10.1093/emboj/cdg469
N1  - 10.1093/emboj/cdg469
UR  - http://dx.doi.org/10.1093/emboj/cdg469
ER  -

TY  - JOUR
AU  - Denvir, M. A.
TI  - Influence of scanning frequency and ultrasonic contrast agent on reproducibility of left ventricular measurements in the mouse
JA  - J. Am. Soc. Echocardiogr.
PY  - 2005///
VL  - 18
SP  - 155
EP  - 162
ER  -

TY  - GEN
TI  - 
ER  -
